Both Semaglutide and Semaglutide belong to a category of therapies called GLP-One receptor activators . These important medicines work by mimicking the body's inherent substance, Glucagon-like Peptide-1, to help lower blood sugar and stimulate a decrease in weight. This similar mechanism of action highlights why such treatments are frequently consi